Maysa M. Abu-khalaf, MD | Authors

Articles

Anthracycline-­Induced Cardiotoxicity: Risk Assessment and Management

March 17, 2009

In the current issue of ONCOLOGY, Hershman and Shao provide a comprehensive review of anthracycline-induced cardiotoxicity (AIC). Risk factors for AIC include age (≤ 18 or ≥ 65 years) at time of treatment, increasing cumulative dose or dose intensity of anthracyclines, mediastinal radiation therapy (RT), and female gender.[1-4]